ClinicalTrials HQ

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Recruiting · NCT07469891 · Registry updated 2026-10-01
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative NeoplasmsHemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, bone marrow disorder, bone marrow neoplasm, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm, primary myelofibrosisRecruitingPhase 12026-10-01NCT07469891

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Prelude Therapeutics Incorporated1

18 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BRCR Global - Coral SpringsCoral SpringsUnited States2
Colorado Blood Cancer InstituteDenverUnited States178
Hospital Clinic de BarcelonaBarcelonaSpain137
Hospital Clínico Universitario de ValenciaValenciaSpain58
Hospital Universitario 12 de OctubreMadridSpain359
Hospital Universitario Ramon y CajalMadridSpain141
Moffitt Cancer CenterTampaUnited States523
Monash Health, Monash Medical CentreClaytonAustralia6
Oncopole Claudius RegaudToulouseFrance17
One Clinical ResearchNedlandsAustralia7
Royal Adelaide HospitalAdelaideAustralia132
Saint-Louis HospitalParisFrance5
START Midwest, LLCGrand RapidsUnited States8
Tennessee Oncology, PLLC - Investigational Drug ServicesNashvilleUnited States7
The University of Texas, MD Anderson Cancer CenterHoustonUnited States11
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials OfficePhiladelphiaUnited States1
Tristar BMTNashvilleUnited States5
UCLA Ronald Reagan Medical CenterLos AngelesUnited States6